Advertisement

Topics

New disease model to facilitate development of ALS and MS therapies

20:00 EDT 15 Apr 2018 | AAAS

(Karolinska Institutet) Researchers at Karolinska Institutet in Sweden have developed a new disease model for neurodegenerative diseases such as ALS and MS that can be used to develop new immunotherapies. The model is described in a publication in the scientific journal Nature Immunology.

Original Article: New disease model to facilitate development of ALS and MS therapies

NEXT ARTICLE

More From BioPortfolio on "New disease model to facilitate development of ALS and MS therapies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...